百仕達控股(01168.HK)2023年收益減少5%至3.608億港元
格隆匯3月28日丨百仕達控股(01168.HK)公吿,截至2023年12月31日止年度,收益減少5%至3.608億港元;公司擁有人應占虧損為2.782億港元;每股基本虧損為4.37港仙。
集團一直積極響應中國政府及香港特區政府持續推動的金融科技發展方向,並努力探索如何優化商業模式及為集團創造新價值。本集團在保持房地產業務和金融服務業務開發的同時,積極與巿場上領先的金融科技企業共同合作並抓緊金融科技巿場發展的機遇,當中包括投資於眾安在綫財產保險股份有限公司("眾安在綫",股份代號:6060),並與其合資成立眾安科技(國際)集團有限公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.